Cytokinetics
CYTK
#2440
Rank
A$10.68 B
Marketcap
A$76.72
Share price
-1.32%
Change (1 day)
-24.29%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2026 (TTM): -A$1.14 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are A$0.11 Billion. In 2025 the company made an earning of -A$1.19 Billion a decrease over its 2024 earnings that were of -A$0.9 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.14 Billion-4.53%
2025 -A$1.19 Billion33.15%
2024 -A$0.9 Billion12.03%
2023 -A$0.8 Billion35.3%
2022 -A$0.59 Billion80.65%
2021 -A$0.33 Billion69.15%
2020 -A$0.2 Billion4.6%
2019 -A$0.19 Billion14.49%
2018 -A$0.17 Billion-16.83%
2017 -A$0.2 Billion-812.8%
2016 A$27.08 M-147.81%
2015 -A$56.66 Million156.05%
2014 -A$22.13 Million-56.56%
2013 -A$50.94 Million-16.48%
2012 -A$61 Million-15.65%
2011 -A$72.31 Million-3.24%
2010 -A$74.73 Million-308.68%
2009 A$35.81 M-141.87%
2008 -A$85.53 Million0.21%
2007 -A$85.34 Million-7.91%
2006 -A$92.67 Million37.42%
2005 -A$67.44 Million16.13%
2004 -A$58.07 Million-19.29%
2003 -A$71.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$16.69 B-1,520.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-A$46.92 Million-96.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$92.02 M-107.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.42 Billion-65.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-A$78.04 Million-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA